HARM REDUCTION THERAPEUTICS INC: Form 990PF, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- HARM REDUCTION THERAPEUTICS INC (EIN 82-2380699)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-11-14
- IRS object ID
- 202403199349101920
- Schema version
- 2023v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990-PF
- Schedule B
- Accounting Fees Schedule
- Acty Not Previously Rpt Expln
- Contractor Compensation Expln
- Legal Fees Schedule
- Other Expenses Schedule
- Other Income Schedule2
- Other Liabilities Schedule
- Other Professional Fees Schedule
- Other Receivables Officers Sch
- Sales Of Inventory List
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-11-14T10:11:28-05:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 251898678 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EG CONLEY PC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 FORESTWOOD DR STE 201 | AddressLine1Txt |
| City | PITTSBURGH | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 152371216 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990PF | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 822380699 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | HARM REDUCTION THERAPEUTICS INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | HARM | BusinessNameControlTxt |
| Phone | 3017188440 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4800 MONTGOMERY LANE STE 640 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MICHAEL HUFFORD | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 3017188440 | PhoneNum |
| Signature | 2024-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | false | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | QUINN M CONLEY | PreparerPersonNm |
| PTIN | P01760641 | PTIN |
| Phone | 4123672001 | PhoneNum |
| Preparation | 2024-11-14 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2024-10-15 13:58:12Z | BuildTS |
Form 990-PF IRS990PF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Change | Yes (X) | AddressChangeInd |
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| FMV Assets EOY | $5,203,391 | FMVAssetsEOYAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contri Rcvd Rev And Expnss | $9,077,748 | ContriRcvdRevAndExpnssAmt |
| Interest On Sav Rev And Expnss | $123,519 | InterestOnSavRevAndExpnssAmt |
| Interest On Sav Net Invst Incm | $123,519 | InterestOnSavNetInvstIncmAmt |
| Interest On Savings Adj Net Incm | $123,519 | InterestOnSavingsAdjNetIncmAmt |
| Gross Sales Less Ret And Allwnc | $970,497 | GrossSalesLessRetAndAllwncAmt |
| Cost Of Goods Sold | $8,600,276 | CostOfGoodsSoldAmt |
| Gross Profit Rev And Expnss | -$7,629,779 | GrossProfitRevAndExpnssAmt |
| Gross Profit Adj Net Incm | -$7,629,779 | GrossProfitAdjNetIncmAmt |
| Other Income Rev And Expnss | $1,558,609 | OtherIncomeRevAndExpnssAmt |
| Other Income Adj Net Incm | $1,558,609 | OtherIncomeAdjNetIncmAmt |
| Total Rev And Expnss | $3,130,097 | TotalRevAndExpnssAmt |
| Total Net Invst Incm | $123,519 | TotalNetInvstIncmAmt |
| Total Adj Net Incm | -$5,947,651 | TotalAdjNetIncmAmt |
| Comp Ofcr Dir Trst Rev And Expnss | $257,386 | CompOfcrDirTrstRevAndExpnssAmt |
| Comp Ofcr Dir Trst Dsbrs Chrtbl | $257,386 | CompOfcrDirTrstDsbrsChrtblAmt |
| Pension Empl Bnft Rev And Expnss | $20,556 | PensionEmplBnftRevAndExpnssAmt |
| Pension Empl Bnft Dsbrs Chrtbl | $20,556 | PensionEmplBnftDsbrsChrtblAmt |
| Legal Fees Rev And Expnss | $349,244 | LegalFeesRevAndExpnssAmt |
| Legal Fees Dsbrs Chrtbl | $349,244 | LegalFeesDsbrsChrtblAmt |
| Accounting Fees Rev And Expnss | $58,566 | AccountingFeesRevAndExpnssAmt |
| Accounting Fees Chrtbl Prps | $41,068 | AccountingFeesChrtblPrpsAmt |
| Other Prof Fees Rev And Expnss | $38,959 | OtherProfFeesRevAndExpnssAmt |
| Other Prof Fees Dsbrs Chrtbl | $38,959 | OtherProfFeesDsbrsChrtblAmt |
| Trav Conf Meeting Rev And Expnss | $1,633 | TravConfMeetingRevAndExpnssAmt |
| Trav Conf Meeting Dsbrs Chrtbl | $946 | TravConfMeetingDsbrsChrtblAmt |
| Other Expenses Rev And Expnss | $2,141,496 | OtherExpensesRevAndExpnssAmt |
| Other Expenses Dsbrs Chrtbl | $2,081,603 | OtherExpensesDsbrsChrtblAmt |
| Tot Opr Expenses Rev And Expnss | $2,867,840 | TotOprExpensesRevAndExpnssAmt |
| Tot Opr Expenses Net Invst Incm | $0 | TotOprExpensesNetInvstIncmAmt |
| Tot Opr Expenses Dsbrs Chrtbl | $2,789,762 | TotOprExpensesDsbrsChrtblAmt |
| Contri Paid Rev And Expnss | $0 | ContriPaidRevAndExpnssAmt |
| Contri Paid Dsbrs Chrtbl | $0 | ContriPaidDsbrsChrtblAmt |
| Total Expenses Rev And Expnss | $2,867,840 | TotalExpensesRevAndExpnssAmt |
| Total Expenses Net Invst Incm | $0 | TotalExpensesNetInvstIncmAmt |
| Total Expenses Dsbrs Chrtbl | $2,789,762 | TotalExpensesDsbrsChrtblAmt |
| Excess Revenue Over Expenses | $262,257 | ExcessRevenueOverExpensesAmt |
| Net Investment Income | $123,519 | NetInvestmentIncomeAmt |
Form990 PF Balance Sheets Form990PFBalanceSheetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cash BOY | $5,439,115 | CashBOYAmt |
| Cash EOY | $376,269 | CashEOYAmt |
| Cash EOYFMV | $376,269 | CashEOYFMVAmt |
| Sav And Temp Cash Invst EOY | $3,831,074 | SavAndTempCashInvstEOYAmt |
| Sav And Temp Cash Invst EOYFMV | $3,831,074 | SavAndTempCashInvstEOYFMVAmt |
| Acct Rcvbl | $970,497 | AcctRcvblAmt |
| Acct Rcvbl EOY | $970,497 | AcctRcvblEOYAmt |
| Acct Rcvbl EOYFMV | $970,497 | AcctRcvblEOYFMVAmt |
| Rcvbl From Officers BOY | $20,655 | RcvblFromOfficersBOYAmt |
| Rcvbl From Officers EOY | $13,581 | RcvblFromOfficersEOYAmt |
| Rcvbl From Officers EOYFMV | $13,581 | RcvblFromOfficersEOYFMVAmt |
| Prepaid Expenses BOY | $12,130 | PrepaidExpensesBOYAmt |
| Prepaid Expenses EOY | $11,970 | PrepaidExpensesEOYAmt |
| Prepaid Expenses EOYFMV | $11,970 | PrepaidExpensesEOYFMVAmt |
| Total Assets BOY | $5,471,900 | TotalAssetsBOYAmt |
| Total Assets EOY | $5,203,391 | TotalAssetsEOYAmt |
| Total Assets EOYFMV | $5,203,391 | TotalAssetsEOYFMVAmt |
| Accounts Payable BOY | $3,037,961 | AccountsPayableBOYAmt |
| Accounts Payable EOY | $2,503,866 | AccountsPayableEOYAmt |
| Other Liabilities BOY | $17 | OtherLiabilitiesBOYAmt |
| Other Liabilities EOY | $3,346 | OtherLiabilitiesEOYAmt |
| Total Liabilities BOY | $3,037,978 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $2,507,212 | TotalLiabilitiesEOYAmt |
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
| No Donor Rstr Net Assests BOY | $2,433,922 | NoDonorRstrNetAssestsBOYAmt |
| No Donor Rstr Net Assests EOY | $2,696,179 | NoDonorRstrNetAssestsEOYAmt |
| Tot Net Ast Or Fund Balances BOY | $2,433,922 | TotNetAstOrFundBalancesBOYAmt |
| Tot Net Ast Or Fund Balances EOY | $2,696,179 | TotNetAstOrFundBalancesEOYAmt |
| Total Liabilities Net Ast BOY | $5,471,900 | TotalLiabilitiesNetAstBOYAmt |
| Total Liabilities Net Ast EOY | $5,203,391 | TotalLiabilitiesNetAstEOYAmt |
Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Net Ast Or Fund Balances BOY | $2,433,922 | TotNetAstOrFundBalancesBOYAmt |
| Excess Revenue Over Expenses | $262,257 | ExcessRevenueOverExpensesAmt |
| Subtotal | $2,696,179 | SubtotalAmt |
| Tot Net Ast Or Fund Balances EOY | $2,696,179 | TotNetAstOrFundBalancesEOYAmt |
Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Income Excise Tax | $1,717 | InvestmentIncomeExciseTaxAmt |
| Subtotal | $1,717 | SubtotalAmt |
| Tax Based On Investment Income | $1,717 | TaxBasedOnInvestmentIncomeAmt |
| Form2220 Attached | Yes (X) | Form2220AttachedInd |
| Es Penalty | $98 | EsPenaltyAmt |
| Tax Due | $1,815 | TaxDueAmt |
Statements Regarding Acty StatementsRegardingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Legislative Political Acty | false | LegislativePoliticalActyInd |
| More Than100 Spent | false | MoreThan100SpentInd |
| Form1120 POL Filed | false | Form1120POLFiledInd |
| Activities Not Previously Rpt | Yes (true) | ActivitiesNotPreviouslyRptInd |
| Changes To Articles Or Bylaws | false | ChangesToArticlesOrBylawsInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Organization Dissolved Etc | false | OrganizationDissolvedEtcInd |
| Section508e Rqr Satisfied | Yes (true) | Section508eRqrSatisfiedInd |
| At Least5000 In Assets | Yes (true) | AtLeast5000InAssetsInd |
| Org Report Or Register State | MD | OrgReportOrRegisterStateCd |
| Org Report Or Register State | PA | OrgReportOrRegisterStateCd |
| Form990 PF Filed With Atty Gen | Yes (true) | Form990PFFiledWithAttyGenInd |
| Private Operating Foundation | false | PrivateOperatingFoundationInd |
| New Substantial Contributors | false | NewSubstantialContributorsInd |
| Own Controlled Entity | false | OwnControlledEntityInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Comply With Public Insp Rqr | Yes (true) | ComplyWithPublicInspRqrInd |
| Website Address | WWW.HARMREDUCTIONTHERAPEUTICS.ORG | WebsiteAddressTxt |
Persons With Books Name PersonsWithBooksName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3017188440 | PhoneNum |
Location Of Books US Address LocationOfBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4800 MONTGOMERY LANE | AddressLine1Txt |
| Address Line2 | STE 640 | AddressLine2Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Foreign Accounts Question | false | ForeignAccountsQuestionInd |
Statements Regarding Acty4720 StatementsRegardingActy4720Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sale Or Exch Disqualified Prsn | false | SaleOrExchDisqualifiedPrsnInd |
| Brrw Or Lend Disqualified Prsn | false | BrrwOrLendDisqualifiedPrsnInd |
| Furn Goods Disqualified Prsn | false | FurnGoodsDisqualifiedPrsnInd |
| Pay Comp Disqualified Prsn | Yes (true) | PayCompDisqualifiedPrsnInd |
| Transfer Ast Disqualified Prsn | false | TransferAstDisqualifiedPrsnInd |
| Payment To Government Official | false | PaymentToGovernmentOfficialInd |
| Acts Fail To Qlfy As Exceptions | false | ActsFailToQlfyAsExceptionsInd |
| Undistributed Income PY | false | UndistributedIncomePYInd |
| Business Holdings | false | BusinessHoldingsInd |
| Jeopardy Investments | false | JeopardyInvestmentsInd |
| Uncorrected PY Jeopardy Invst | false | UncorrectedPYJeopardyInvstInd |
| Influence Legislation | false | InfluenceLegislationInd |
| Influence Election | false | InfluenceElectionInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Noncharitable Purpose | false | NoncharitablePurposeInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp
Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee Benefit ProgramEmployeeBenefitProgramAmt | Expense Account Other AllwncExpenseAccountOtherAllwncAmt |
|---|---|---|---|---|---|---|---|---|
| JOHN PINNEY | ||||||||
| 4800 MONTGOMERY LANE SUITE 640 | BETHESDA | MD | 20814 | CHAIRMAN, SE | 8.00 | $0 | $0 | $0 |
| MICHAEL HUFFORD | ||||||||
| 397 LEE RD | BURGETTSTOWN | PA | 15021 | CEO | 24.00 | $120,000 | $0 | $0 |
| ELLIOT MILLENSON | ||||||||
| 10805 PLEASANT HILL DRIVE | POTOMAC | MD | 20854 | DIRECTOR | 1.00 | $0 | $0 | $0 |
| JUDY ASHWORTH | ||||||||
| 1204 SHERMAN AVENUE | EVANSTON | IL | 60202 | CHIEF MEDICA | 1.00 | $0 | $0 | $0 |
| JAMES KELLY | ||||||||
| 34 EDGEWOOD ROAD | EDISON | NJ | 08820 | PRESIDENT, T | 40.00 | $137,386 | $0 | $0 |
| ROBERT GOUGELET | ||||||||
| 610 SYCAMORE STREET | SHELBURNE | VT | 05482 | DIRECTOR | 1.00 | $0 | $0 | $0 |
| GEORGE QUESNELLE | ||||||||
| 366 FORT HOWELL DRIVE | HILTON HEAD | SC | 29926 | DIRECTOR | 1.00 | $0 | $0 | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Comp Of Hghst Pd Empl Or NONE | NONE | CompOfHghstPdEmplOrNONETxt |
Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Service TypeServiceTypeTxt | CompensationCompensationAmt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|
| QUALITY BY DESIGN LLC | ||||||
| 6205 MOTTS VILLAGE ROAD | WILMINGTON | NC | 28412 | CONSULTING | $273,952 | |
| K&L GATES LLP | ||||||
| 210 SIXTH AVE | PITTSBURGH | PA | 152222613 | LEGAL | $255,803 | |
| PINNEY ASSOCIATES | ||||||
| 4800 MONTGOMERY LANE | BETHESDA | MD | 20814 | CONSULTING | $255,125 | STE 640 |
| MANNION CONSULTING LLC | ||||||
| 10 N 8TH STREET | PERKASIE | PA | 18944 | CONSULTING | $249,702 | |
Summary Of Direct Chrtbl Acty SummaryOfDirectChrtblActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | THROUGHOUT 2023, HARM REDUCTION THERAPEUTICS (HRT) CONTINUED ITS WORK AS AN INDEPENDENT NONPROFIT FOCUSED EXCLUSIVELY ON SAVING LIVES THAT WOULD OTHERWISE BE LOST TO OPIOID OVERDOSE BY MAKING ITS NALOXONE PRODUCT RIVIVE (NALOXONE HCL NASAL SPRAY 3MG) AVAILABLE OVER-THE- COUNTER FREE OF CHARGE OR AT THE LOWEST POSSIBLE COST. RIVIVE USES AN EASY-TO-USE STANDARD UNIT DOSE SYSTEM THAT CAN BE USED IN AN EMERGENCY TO REVERSE THE LIFE-THREATENING EFFECTS OF KNOWN OR SUSPECTED OPIOID OVERDOSE. EACH RIVIVE NASAL SPRAY DEVICE CONTAINS ONE DOSE OF NALOXONE. IT IS EXCLUSIVELY AVAILABLE IN TWIN PACKS CONTAINING TWO SINGLE-DOSE DEVICES. IT IS SAFE TO KEEP ADMINISTERING RIVIVE EVERY TWO TO THREE MINUTES UNTIL THE PERSON WAKES UP FROM THEIR OPIOID OVERDOSE. | Description1Txt |
| Expenses1 | $8,600,276 | Expenses1Amt |
Sum Of Program Related Invst SumOfProgramRelatedInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | N/A | Description1Txt |
Minimum Investment Return MinimumInvestmentReturnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Average Monthly FMV Of Sec | $0 | AverageMonthlyFMVOfSecAmt |
| Average Monthly Cash Balances | $4,966,430 | AverageMonthlyCashBalancesAmt |
| FMV All Other Noncharitable Ast | $0 | FMVAllOtherNoncharitableAstAmt |
| Total FMV Of Unused Assets | $4,966,430 | TotalFMVOfUnusedAssetsAmt |
| Adjusted Total FMV Of Unused Ast | $4,966,430 | AdjustedTotalFMVOfUnusedAstAmt |
| Cash Deemed Charitable | $74,496 | CashDeemedCharitableAmt |
| Net Vl Noncharitable Assets | $4,891,934 | NetVlNoncharitableAssetsAmt |
| Minimum Investment Return | $244,597 | MinimumInvestmentReturnAmt |
Distributable Amount DistributableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Minimum Investment Return | $244,597 | MinimumInvestmentReturnAmt |
| Tax Based On Investment Income | $1,717 | TaxBasedOnInvestmentIncomeAmt |
| Total Tax | $1,717 | TotalTaxAmt |
| Distributable Before Adj | $242,880 | DistributableBeforeAdjAmt |
| Distributable Before Ded | $242,880 | DistributableBeforeDedAmt |
| Distributable As Adjusted | $242,880 | DistributableAsAdjustedAmt |
PF Qualifying Distributions PFQualifyingDistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expenses And Contributions | $2,789,762 | ExpensesAndContributionsAmt |
| Qualifying Distributions | $2,789,762 | QualifyingDistributionsAmt |
Undistributed Income UndistributedIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Distributable As Adjusted | $242,880 | DistributableAsAdjustedAmt |
| Excess Distribution Cyov Yr5 | $61,394 | ExcessDistributionCyovYr5Amt |
| Excess Distribution Cyov Yr4 | $1,559,721 | ExcessDistributionCyovYr4Amt |
| Excess Distribution Cyov Yr3 | $5,136,070 | ExcessDistributionCyovYr3Amt |
| Excess Distribution Cyov Yr2 | $3,651,086 | ExcessDistributionCyovYr2Amt |
| Excess Distribution Cyov Yr1 | $6,722,718 | ExcessDistributionCyovYr1Amt |
| Total Excess Distribution Cyov | $17,130,989 | TotalExcessDistributionCyovAmt |
| Qualifying Distributions | $2,789,762 | QualifyingDistributionsAmt |
| Applied To Current Year | $242,880 | AppliedToCurrentYearAmt |
| Remaining Distri From Corpus | $2,546,882 | RemainingDistriFromCorpusAmt |
| Total Corpus | $19,677,871 | TotalCorpusAmt |
| Undistributed Income CY | $0 | UndistributedIncomeCYAmt |
| Excess Distri Cyov From Yr5 | $61,394 | ExcessDistriCyovFromYr5Amt |
| Excess Distri Cyov To Next Yr | $19,616,477 | ExcessDistriCyovToNextYrAmt |
| Excess From Year4 | $1,559,721 | ExcessFromYear4Amt |
| Excess From Year3 | $5,136,070 | ExcessFromYear3Amt |
| Excess From Year2 | $3,651,086 | ExcessFromYear2Amt |
| Excess From Year1 | $6,722,718 | ExcessFromYear1Amt |
| Excess From Current Year | $2,546,882 | ExcessFromCurrentYearAmt |
Supplementary Information SupplementaryInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Only Contri To Preselected | Yes (X) | OnlyContriToPreselectedInd |
Analysis Income Producing Acty AnalysisIncomeProducingActyGrp
Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Related Or Exempt Function Incm | $123,519 | RelatedOrExemptFunctionIncmAmt |
Gross Profit Loss Sls Of Invntry GrossProfitLossSlsOfInvntryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | 41 | ExclusionCd |
| Exclusion | -$7,629,779 | ExclusionAmt |
Other Revenue Described OtherRevenueDescribedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | REFUND OF PRIOR YEAR EXPENS | Desc |
| Related Or Exempt Function Incm | $1,558,609 | RelatedOrExemptFunctionIncmAmt |
Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | -$7,629,779 | ExclusionAmt |
| Related Or Exempt Function Incm | $1,682,128 | RelatedOrExemptFunctionIncmAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Income Producing Acty | -$5,947,651 | TotalIncomeProducingActyAmt |
Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trnsfr Of Cash To Nonchrtbl EO | false | TrnsfrOfCashToNonchrtblEOInd |
| Trnsfr Other Asset Nonchrtbl EO | false | TrnsfrOtherAssetNonchrtblEOInd |
| Sales Or Exchanges Of Assets | false | SalesOrExchangesOfAssetsInd |
| Purchase Of Assets Nonchrtbl EO | false | PurchaseOfAssetsNonchrtblEOInd |
| Rental Of Facilities Oth Assets | false | RentalOfFacilitiesOthAssetsInd |
| Reimbursement Arrangements | false | ReimbursementArrangementsInd |
| Loans Or Loan Guarantees | false | LoansOrLoanGuaranteesInd |
| Performance Of Services Etc | false | PerformanceOfServicesEtcInd |
| Sharing Of Facilities Etc | false | SharingOfFacilitiesEtcInd |
| Relationships Nonchrtbl EO | false | RelationshipsNonchrtblEOInd |
Schedule B IRS990ScheduleB
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| General Rule | Yes (X) | GeneralRuleInd |
Contributor Information ContributorInformationGrp (2 entries)
| ContributorContributorNum | Address Line1ContributorUSAddress/AddressLine1Txt | CityContributorUSAddress/CityNm | State AbbreviationContributorUSAddress/StateAbbreviationCd | ZIPContributorUSAddress/ZIPCd | Total ContributionsTotalContributionsAmt | Person ContributionPersonContributionInd | Address Line2ContributorUSAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|
| PURDUE PHARMA | |||||||
| 1 | 201 TRESSER BOULEVARD | STAMFORD | CT | 069013431 | $9,000,000 | Yes (X) | |
| PINNEY ASSOCIATES | |||||||
| 2 | 4800 MONTGOMERY LANE | BETHESDA | MD | 20814 | $77,748 | Yes (X) | STE 640 |
Accounting Fees Schedule AccountingFeesSchedule
Accounting Fees Detail AccountingFeesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Category | INDIRECT ACCOUNTING FEES | CategoryTxt |
| Amt | $58,566 | Amt |
| Disbursements Charitable Prps | $41,068 | DisbursementsCharitablePrpsAmt |
Acty Not Previously Rpt Expln ActyNotPreviouslyRptExpln
| Field | Value | IRS element (for citing) |
|---|---|---|
| Explanation | THROUGHOUT 2023, HARM REDUCTION THERAPEUTICS (HRT) CONTINUED ITS WORK AS AN INDEPENDENT NONPROFIT FOCUSED EXCLUSIVELY ON SAVING LIVES THAT WOULD OTHERWISE BE LOST TO OPIOID OVERDOSE BY MAKING ITS NALOXONE PRODUCT - RIVIVE (NALOXONE HCL NASAL SPRAY 3MG) - AVAILABLE OVER-THE-COUNTER FREE OF CHARGE OR AT THE LOWEST POSSIBLE COST. RIVIVE USES AN EASY-TO-USE STANDARD UNIT DOSE SYSTEM THAT CAN BE USED IN AN EMERGENCY TO REVERSE THE LIFE-THREATENING EFFECTS OF KNOWN OR SUSPECTED OPIOID OVERDOSE. EACH RIVIVE NASAL SPRAY DEVICE CONTAINS ONE DOSE OF NALOXONE. IT IS EXCLUSIVELY AVAILABLE IN TWIN PACKS CONTAINING TWO SINGLE- DOSE DEVICES. IT IS SAFE TO KEEP ADMINISTERING RIVIVE EVERY TWO TO THREE MINUTES UNTIL THE PERSON WAKES UP FROM THEIR OPIOID OVERDOSE. 2023 WAS A SEMINAL YEAR FOR RIVIVE, AND HOPEFULLY WILL MARK A TURNING POINT IN THE ONGOING OPIOID CRISIS. IN LATE JULY 2023, THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVED OVER-THE-COUNTER RIVIVE FOR THE EMERGENCY TREATMENT OF OPIOID OVERDOSE. THIS CRITICAL MILESTONE WILL HELP PREVENT OPIOID OVERDOSE DEATHS BY MAKING FREE OR LOW-COST OVER-THE-COUNTER (OTC) NALOXONE NASAL SPRAY AVAILABLE TO EVERYONE IN THE UNITED STATES. NO COMPANY, ENTITY, OR INDIVIDUAL WILL PROFIT FROM SALES OF RIVIVE. SINCE 2017, MORE THAN 290,000 PEOPLE ACROSS THE U.S. HAVE DIED OF AN OPIOID OVERDOSE. HRT STANDS BEHIND THE PRINCIPLE ARTICULATED BY THE WHITE HOUSE AND OFFICE OF NATIONAL DRUG CONTROL POLICY DIRECTOR DR. RAHUL GUPTA THAT "NO ONE WHO NEEDS OVERDOSE REVERSAL MEDICATIONS SHOULD LACK ACCESS BECAUSE OF COSTS OR AVAILABILITY." HRT BEGAN MANUFACTURING RIVIVE AT-RISK TO MINIMIZE THE TYPICAL LAG BETWEEN FDA APPROVAL AND LAUNCH OF A NEW PRODUCT. AS A RESULT, HRT ANTICIPATED THAT RIVIVE WOULD BE AVAILABLE IN EARLY 2024 PRIMARILY TO U.S. HARM REDUCTION ORGANIZATIONS AND STATE GOVERNMENTS FOR COSTS LOWER THAN OTHER OPIOID ANTAGONIST NASAL SPRAYS. IN DECEMBER 2023, HRT SHIPPED ITS FIRST ORDER RIVIVE TO THE NONPROFIT REMEDY ALLIANCE/FOR THE PEOPLE (HTTPS://REMEDYALLIANCEFTP.ORG), MARKING A CRUCIAL STEP IN HRT'S SINGULAR MISSION OF PREVENTING OPIOID OVERDOSE DEATHS BY MAKING FREE-OF-CHARGE OR LOW-COST OVER-THE-COUNTER NALOXONE AVAILABLE TO EVERYONE IN THE UNITED STATES, PRIMARILY THROUGH NONPROFIT COMMUNITY HARM REDUCTION ORGANIZATIONS AS WELL AS STATE AND LOCAL GOVERNMENTS. LASTLY, BECAUSE OF HRT'S WORK DEVELOPING AND OBTAINING FDA APPROVAL FOR RIVIVE, MANUFACTURERS OF OTHER NALOXONE PRODUCTS FINALLY APPLIED FOR FDA OTC APPROVAL OF THEIR PRODUCTS , AFTER YEARS OF DELAY PRIOR TO OUR WORK, MEANING THAT HRT HELPED TO FUNDAMENTALLY IMPROVE THE ACCESSIBILITY OF LIFE-SAVING NALOXONE PRODUCTS ACROSS THE U.S. | ExplanationTxt |
Contractor Compensation Expln ContractorCompensationExpln
Contractor Comp Expln ContractorCompExplnGrp (4 entries)
| ExplanationExplanationTxt |
|---|
| QUALITY BY DESIGN LLC |
| DRUG DEVELOPMENT CONSULTING |
| K&L GATES LLP |
| LEGAL FEES |
| PINNEY ASSOCIATES |
| ADMINISTRATIVE CONSULTING |
| MANNION CONSULTING LLC |
| DRUG DEVELOPMENT CONSULTING |
Legal Fees Schedule LegalFeesSchedule
Legal Fees LegalFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Category | INDIRECT LEGAL FEES | CategoryTxt |
| Legal Fees | $349,244 | LegalFeesAmt |
| Disbursements Charitable Prps | $349,244 | DisbursementsCharitablePrpsAmt |
Other Expenses Schedule OtherExpensesSchedule
Other Expenses Schedule OtherExpensesScheduleGrp (13 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|
| EXPENSES | ||
| PAYROLL PROCESSING FEES | $2,406 | $2,406 |
| R&D CONSULTING | $837,830 | $793,386 |
| R&D TESTING & STUDIES | $301,687 | $301,687 |
| OTHER R&D | $243,046 | $243,046 |
| CONSULTING | $564,045 | $553,465 |
| IT | $41,851 | $41,839 |
| REGULATORY | $5,773 | $5,773 |
| CONSUMER SUPPORT | $398 | $398 |
| BANK CHARGES | $1,530 | $1,530 |
| INSURANCE | $56,839 | $56,839 |
| ADVERTISING | $78,400 | $78,400 |
| OFFICE EXPENSE | $7,691 | $2,834 |
Other Income Schedule2 OtherIncomeSchedule2
Other Income Detail OtherIncomeDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | REFUND OF PRIOR YEAR EXPENSE | Desc |
| Revenue And Expenses Per Books | $1,558,609 | RevenueAndExpensesPerBooksAmt |
| Adjusted Net Income | $1,558,609 | AdjustedNetIncomeAmt |
Other Liabilities Schedule OtherLiabilitiesSchedule
Other Liabilities Detail OtherLiabilitiesDetail (2 entries)
| DescDesc | BOY Book ValueBOYBookValueAmt | EOY Book ValueEOYBookValueAmt |
|---|---|---|
| ACCRUED EXPENSES | $17 | |
| PAYROLL LIABILITIES | $3,346 |
Other Professional Fees Schedule OtherProfessionalFeesSchedule
Other Professional Fees Detail OtherProfessionalFeesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Category | INDIRECT OTHER PROFESSIONAL FEES | CategoryTxt |
| Amt | $38,959 | Amt |
| Disbursements Charitable Prps | $38,959 | DisbursementsCharitablePrpsAmt |
Other Receivables Officers Sch OtherReceivablesOfficersSch
Officer Other Rcvbl OfficerOtherRcvblGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Borrower Person | MICHAEL HUFFORD | BorrowerPersonNm |
| Borrower Title | PRESIDENT | BorrowerTitleTxt |
| Loan Original | $20,655 | LoanOriginalAmt |
| Balance Due | $13,581 | BalanceDueAmt |
| Note | 2021-12 | NoteDt |
| Loan Purpose | TAX PAYMENTS | LoanPurposeTxt |
| Consideration FMV | $13,581 | ConsiderationFMVAmt |
Sales Of Inventory List SalesOfInventoryList
Inventory Sale InventorySaleGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales | $970,497 | GrossSalesAmt |
| Cost Of Goods Sold | $8,600,276 | CostOfGoodsSoldAmt |
| Net | -$7,629,779 | NetAmt |